Papers in BMJ Oncology
Page 1 · newest first
- Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC)BMJ Oncology · 2026
- Looking inside the primary tumour: what drives immunotherapy response in renal cell carcinoma?BMJ Oncology · 2026
- Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched studyBMJ Oncology · 2026
- Identification and management of genetic susceptibility to cancer: UK perspectiveBMJ Oncology · 2026
- Ovarian cancer diagnosis within 28 days after an emergency admission to hospital: national population-based study of patient risk factors and cancer characteristics using routinely collected data in EnglandBMJ Oncology · 2026
- Future of radiotheranosticsBMJ Oncology · 2026
- Impact of immune checkpoint inhibitors on pregnancy: current evidence and future directionsBMJ Oncology · 2026
- Ipsilateral recurrences after kidney-sparing surgery for upper tract urothelial carcinoma: a systematic review and meta-analysisBMJ Oncology · 2026
- Aligning awareness, systems and policy to increase equitable access to genomically driven cancer careBMJ Oncology · 2026
- Cytotoxic T-cell exhaustion analyses by in situ single-cell immunofluorescence in relation to colorectal cancer patient age, tissue bacteria and mortalityBMJ Oncology · 2026
- Incidence of new-onset depression after colorectal cancer diagnosis and associated mortality: a population-based cohort studyBMJ Oncology · 2026
- Optimising cancer immunotherapy and emerging data supporting de-escalation strategiesBMJ Oncology · 2026
- Active surveillance for a small low-risk papillary thyroid cancer: a 10-year prospective, observational study in an Italian tertiary care centreBMJ Oncology · 2026
- Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countriesBMJ Oncology · 2026
- Unveiling the variations in penile cancer care: identifying knowledge gaps and research prioritiesBMJ Oncology · 2026
- Correction for ‘Impact of loneliness on cancer mortality: a systematic review and meta-analysis’BMJ Oncology · 2026
- Treatment of oligometastatic lung cancers: new data, new drivers, new approachesBMJ Oncology · 2026
- Beyond a two-tier model: equitable molecular diagnostics for allBMJ Oncology · 2026
- Inequalities in cancer diagnostic outcomes for patients with a learning disability: a retrospective cohort study in EnglandBMJ Oncology · 2026
- Lost in translation: why genomic breakthroughs are not reaching patientsBMJ Oncology · 2026
- Foundation models in computational pathology: methods, applications and clinical implicationsBMJ Oncology · 2026
- Testicular cancer incidence and associations with prior epididymo-orchitis or urinary tract infections: a national cohort study in Sweden, 1964–2018BMJ Oncology · 2026
- CXCR4 in colorectal cancer: from prognostic marker to immunotherapy guide?BMJ Oncology · 2026
- Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messagingBMJ Oncology · 2026
- Beyond the label: patient-reported outcomes and post-approval communication in oncologyBMJ Oncology · 2026
- Incident anaemia as a marker of cancer and all-cause mortality: evidence from 380 114 adults in the population-based Stockholm Early Detection of Cancer Study (STEADY-CAN) cohortBMJ Oncology · 2026
- Analgesic efficacy in women and men with cancer pain, treated with strong opioids: are there differences?BMJ Oncology · 2026
- World Radiotherapy Awareness Day: how we can make a differenceBMJ Oncology · 2026
- When herds overgraze: the cost of conformity in oncology drug developmentBMJ Oncology · 2026
- CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerBMJ Oncology · 2026
- BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trialsBMJ Oncology · 2026
- Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspectiveBMJ Oncology · 2026
- Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detectionBMJ Oncology · 2026
- Rethinking cancer care in conflict settings: lessons from UkraineBMJ Oncology · 2026
- Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directionsBMJ Oncology · 2026
- Cancer care in wartime Ukraine: disruption, resilience and recoveryBMJ Oncology · 2026
- SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerBMJ Oncology · 2026
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategiesBMJ Oncology · 2026
- Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectivesBMJ Oncology · 2026
- Human and financial consequences of herding in oncology drug development: clinical trials of TIGIT inhibitorsBMJ Oncology · 2026
- Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic reviewBMJ Oncology · 2026
- Global determinants of cervical cancer outcomes: a health systems analysisBMJ Oncology · 2026
- Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in EnglandBMJ Oncology · 2026
- Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practiceBMJ Oncology · 2026
- Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II–III non-small cell lung cancer in Sri LankaBMJ Oncology · 2026
- Beyond auto-segmentation: the case for planning and dosimetry AI in head and neck radiation oncologyBMJ Oncology · 2026
- Beyond stage and HPV status: the evolving landscape and future of multidisciplinary deintensification in human papillomavirus-related oropharyngeal cancerBMJ Oncology · 2026
- Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF -mutant advanced melanoma: A matching-adjusted indirect comparisonBMJ Oncology · 2025
- Breast cancer awareness and breast self-examination among females in the Middle East and North Africa: a multinational cross-sectional studyBMJ Oncology · 2025
- Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trialsBMJ Oncology · 2025